Once-Daily Oral Levofloxacin Monotherapy versus Piperacillin/Tazobactam Three Times a Day: A Randomi...
Once-Daily Oral Levofloxacin Monotherapy versus Piperacillin/Tazobactam Three Times a Day: A Randomized Controlled Multicenter Trial in Patients with Febrile Neutropenia
About this item
Full title
Author / Creator
Publisher
Tokyo: Springer
Journal title
Language
English
Formats
Publication information
Publisher
Tokyo: Springer
Subjects
More information
Scope and Contents
Contents
A prospective, randomized, controlled multicenter trial was performed to evaluate the efficacy and safety of once-daily oral monotherapy with 500 mg levofloxacin in comparison with 4.5 g piperacillin/tazobactam 3 times a day in patients with low-risk febrile neutropenia. Low risk was defined by oral temperature > or = 38.5 degrees C on one occasion...
Alternative Titles
Full title
Once-Daily Oral Levofloxacin Monotherapy versus Piperacillin/Tazobactam Three Times a Day: A Randomized Controlled Multicenter Trial in Patients with Febrile Neutropenia
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_217392898
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_217392898
Other Identifiers
ISSN
0925-5710
E-ISSN
1865-3774
DOI
10.1007/BF02983537
